静脉注射沙丁胺醇治疗儿童高钾血症

Treatment of hyperkalemia in children with intravenous salbutamol.

作者信息

Noyan A, Anarat A, Pirti M, Yurdakul Z

机构信息

Cukurova University School of Medicine, Department of Pediatric Nephrology, Adana, Turkey.

出版信息

Acta Paediatr Jpn. 1995 Jun;37(3):355-7. doi: 10.1111/j.1442-200x.1995.tb03329.x.

DOI:10.1111/j.1442-200x.1995.tb03329.x

PMID:7645387

Abstract

The aim of this study is to investigate the efficacy and safety of intravenous salbutamol in hyperkalemia. Fourteen children with chronic renal failure, three with acute renal failure and hyperkalemia were treated by intravenous infusions of 4 micrograms/kg salbutamol. Reductions in the mean plasma potassium (K+) concentrations obtained at 40 to 120 min after therapy were statistically significant when compared with the mean plasma K+ concentration at the beginning of therapy (P < 0.01).

摘要

本研究的目的是探讨静脉注射沙丁胺醇治疗高钾血症的疗效和安全性。对14例慢性肾功能衰竭患儿以及3例急性肾功能衰竭合并高钾血症患儿静脉输注4微克/千克沙丁胺醇进行治疗。与治疗开始时的平均血浆钾（K+）浓度相比，治疗后40至120分钟时平均血浆钾浓度的降低具有统计学意义（P < 0.01）。